SCHEMBL19660413

SCHEMBL19660413

Cc1cncc2cc(-c3cnn(C)c3)c(C(F)F)cc12

nearest known ligand 0.47

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CREBBP Q92793 19/20 0.47
BRD4 O60885 2/20 0.47
CCNC P24863 1/20 0.38
CDK8 P49336 1/20 0.38
EP300 Q09472 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19643965 0.86 CREBBP (0.47) CREBBPBRD4CCNCCDK8EP300
SCHEMBL21237550 0.86 CREBBP (0.47) CREBBPBRD4EP300
SCHEMBL19663200 0.86 CREBBP (0.47) CREBBPBRD4EP300
SCHEMBL30878013 0.86 CREBBP (0.47) CREBBPBRD4CCNCCDK8EP300
SCHEMBL21237382 0.84 CREBBP (0.45) CREBBPBRD4EP300
SCHEMBL21419225 0.84 CREBBP (0.49) CREBBPBRD4EP300
SCHEMBL24368131 0.82 CREBBP (0.44) CREBBPBRD4EP300
SCHEMBL19643357 0.78 CREBBP (0.42) CREBBPBRD4EP300
SCHEMBL30878068 0.78 CREBBP (0.42) CREBBPBRD4EP300
SCHEMBL17794959 0.77 CREBBP (0.47) CREBBPBRD4EP300

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3464286-B1 PYRAZOLOPYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER GENENTECH INC (US) 2021-08-18 EP disclosed
WO-2017205538-A1 PYRAZOLOPYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER GENENTECH, INC. (US) 2017-11-30 WO disclosed